Prognostic value of clinical markers of reperfusion in patients with acute myocardial infarction treated by thrombolytic therapy

American Heart Journal

Volumn 134, Issue 4, 1997, Pages 631-638

  Iparraguirre, H P ^a   Conti, C ^a   Grancelli, H ^a   Ohman, E M ^a   Calandrelli, M ^a   Volman, S ^a   Garber, V ^a  

^a Blanco Encalada 3936   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; CREATINE KINASE; STREPTOKINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOGRAPHY; ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REPERFUSION; ST SEGMENT ELEVATION;

EID: 0030663828     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(97)70045-0     Document Type: Article

References (32)

1. FH Sheehan DG Mathey J Schofer HT Dodge EL Bolson Factors that determine recovery of left ventricular function after thrombolysis in patients with acute myocardial infarction Circulation 71 1985 1121 1128
2. FH Sheehan E Braunwald P Canner HT Dodge J Gore P Van Natta The effects of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI phase I) Trial Circulation 75 1987 817 829
3. TF Christian RS Schwartz RJ Gibbons Determinants of infarct size in reperfusion therapy for acute myocardial infarction Circulation 86 1992 81 90
4. HD White DB Cross JM Elliot RM Norris TW Yee Long-term prognostic importance of patency of infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction Circulation 89 1994 61 67
5. The GUSTO Angiographic Investigators The effects of tissue plasminogen activator, streptokinase or both on coronary-artery patency, ventricular function and survival after acute myocardial infarction N Engl J Med 329 1993 1615 1622
6. P Brugada B Waldwacker Y Kersschot M Zehender HJ Wellens Ventricular arrhythmias initiated by programmed stimulation in four groups of patients with healed myocardial infarction J Am Coll Cardiol 8 1986 1035 1040
7. ES Gang AS Lew MA Hong FZ Wang CA Siebert T Peter Decreased incidence of ventricular late potential after successful thrombolytic therapy for acute myocardial infarction N Engl J Med 321 1989 712 716
8. SH Honhloser P Franck T Klingheber M Zabel H Just Open infarct artery, late potentials, and other prognostic factors in patients after acute myocardial infarction in the thrombolytic era. A prospective trial Circulation 90 1994 1747 1756
9. M Galvani F Ottani D Ferrini F Sorbello F Rusticalli Patency of the infarct-related artery and left ventricular function as the major determinants of survival after Q-wave acute myocardial infarction Am J Cardiol 71 1993 1 7
10. MW Krucoff CE Green IE Sattler FC Miller RS Pallas KM Kent Noninvasive detection of coronary artery patency using continuous ST-segment monitoring Am J Cardiol 57 1986 916 922
11. WS Hillis KJ Hogg ST segment changes as a surrogate end point in coronary thrombolysis [editorial] Br Heart J 64 1990 111 112
12. GI Barbash A Roth H Hod HI Miller S Rath Y Har-Zahav Rapid resolution of ST elevation and prediction of clinical outcome in patients undergoing thrombolysis with alteplase (recombinant tissue-type plasminogen activator): results of the Israeli Study of Early Intervention in Myocardial Infarction Br Heart J 64 1990 241 247
13. RK Saran M Been SS Furniss T Hawkins DS Reid Reduction in ST-segment elevation after thrombolysis predict either coronary reperfusion or preservation of left ventricular function Br Heart J 64 1990 113 117
14. BS Lewis W Ganz P Larmee B Cercek H Hod PK Shah Usefulness of rapid initial increase in plasma creatine kinase activity as a marker of reperfusion during thrombolytic therapy for acute myocardial infarction Am J Cardiol 62 1988 20 24
15. W Ganz Y. Geft PK Shah AS Lew L Rodriguez T Weiss Intravenous streptokinase in evolving acute myocardial infarction Am J Cardiol 53 1984 1209 1216
16. BJ Kircher EJ Topol WN O’Neill B Pitt Prediction of infarct coronary artery recanalization after intravenous thrombolytic therapy Am J Cardiol 59 1987 513 515
17. LD Hillis S Forman E Braunwald the Thrombolysis in Myocardial Infarction TIMI Phase II Co-Investigators Risk stratification before thrombolytic therapy in patients with acute myocardial infarction J Am Coll Cardiol 16 1990 313 315
18. H Pomés Iparraguirre A Piombo G Romero on behalf of the ECLA Collaborative Group Prognostic value of clinical markers of early reperfusion after thrombolytic therapy in acute myocardial infarction. Implications for patients selection for further aggressive interventions [abstract] Eur Heart J 12 Suppl 1991 297
19. R Califf W O’Neil RS Stack the TAMI Study Group Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis Ann Intern Med 104 1988 658 662
20. AC Piombo CD Tajer H Pomés Iparraguirre Posthrombolysis noninvasive criteria of reperfusion in acute myocardial infarction: correlation with angiographic patency and ventricular function Rev Arg Cardiol 59 1991 222 228
21. SH Honhloser M Zabel W Kasper T Meinertz H Just Assessment of coronary artery patency after thrombolytic therapy: accurate prediction utilizing the combined analysis of three noninvasive markers J Am Coll Cardiol 18 1991 44 49
22. MW Krucoff MA Croll JE Pope CR Granger CM O’Connor KN Sigmon for the TAMI 7 study group: Continuous 12-lead ST-segment recovery analysis in the TAMI 7 Study Performance of a noninvasive method for real-time detection of failed myocardial reperfusion Circulation 88 1993 437 446
23. EM Ohman RH Christenson RM Califf BS George JK Samaha DJ Keriakes Noninvasive detection of reperfusion after thrombolysis based on serum creatine kinase MB changes and clinical variables. TAMI 7 Study Group Am Heart J 126 1993 819 826
24. L Relik van Wely RF Visser JM van der Pol I Bartholomeus JE Couvée H Drost Angiographically assessed coronary arterial patency and reocclusion in patients with acute myocardial infarction treated with anistreplase: results of the anistreplase reocclusion multicenter study (ARMS) Am J Cardiol 68 1991 296 300
25. MW Krucoff EM Ohman KM Trollinger R Christensen ST Sawchak A Shah Noninvasive definition of failed reperfusion at the bedside: looking beyond the tip of the catheter RM Califf DB Mark GS Wagner Acute coronary care 1995 Mosby St. Louis 443 468
26. F Mauri AP Maggioni MG Franzosi A simple electrocardiographic predictor of the outcome of patients with acute myocardial infarction treated with a thrombolytic agent. A Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI-2) derived analysis J Am Coll Cardiol 26 1994 600 607
27. KL Lee LH Woodlief EJ Topol D Weaver A Betriu J Col for the GUSTO-I Investigators Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41,021 patients Circulation 95 1995 1659 1668
28. The GUSTO Investigators An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction New Engl J Med 329 1993 673 682
29. ER Bates EJ Topol Limitations of thrombolytic therapy for acute myocardial infarction complicated by congestive heart failure and cardiogenic shock J Am Coll Cardiol 18 1991 1077 1084
30. Grupo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico GISSI Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction Lancet 1 1986 397 402
31. The International Study Group In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin Lancet 336 1990 71 75
32. Fibrinolytic Therapy Trialists FTT Collaborative Group Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients Lancet 343 1994 311 322